Position in VTRS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,209,914
+$2,205,657 QoQ
Shares Held
681,711
+21.2% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GUGGENHEIM CAPITAL LLC holds $73,564,946 across 16 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
361,944 | $42,785,398 | |
| 2 | VTRS |
Viatris Inc
This page
|
681,711 | $9,209,914 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
9,720 | $5,763,765 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
38,866 | $5,120,206 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
79,787 | $2,403,183 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
62,931 | $1,505,938 | |
| 7 | HIMS |
Hims & Hers Health, Inc.
|
63,099 | $1,309,935 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
94,309 | $1,306,179 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,209,914 | 681,711 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,004,257 | 562,591 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $7,954,411 | 803,476 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,938,537 | 776,992 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $7,582,018 | 870,496 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $11,190,058 | 898,800 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $11,141,013 | 959,605 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $10,982,862 | 1,033,195 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $12,923,114 | 1,082,338 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $13,824,136 | 1,276,467 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $11,102,427 | 1,126,007 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $11,565,651 | 1,158,883 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $7,726,080 | 803,127 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $8,897,154 | 799,385 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $5,317,620 | 624,134 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,340,180 | 510,046 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $7,534,638 | 692,522 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $7,815,143 | 577,616 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,812,749 | 502,786 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,948,997 | 626,242 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $10,187,858 | 729,267 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $9,905,701 | 528,586 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||